65862-0391 Ondansetron

Product NDC:

65862-0391

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 8.0

Unit: mg/1

Packages:

Code: 65862-0391-01

Description: 1 BLISTER PACK in 1 CARTON (65862-391-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Effective Date: March 24, 2021

Discontinued:

Code: 65862-0391-10

Description: 3 BLISTER PACK in 1 CARTON (65862-391-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Effective Date: April 12, 2010

Discontinued:

Code: 65862-0391-30

Description: 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-30)

Effective Date: April 12, 2010

Discontinued:

Code: 65862-0391-66

Description: 6000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-66)

Effective Date: April 12, 2010

Discontinued:

Code: 65862-0391-02

Description: 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-02)

Effective Date: April 12, 2024

Discontinued:

Code: 65862-0391-05

Description: 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (65862-391-05)

Effective Date: April 12, 2024

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC